False-positive buprenorphine EIA urine toxicology results due to high dose morphine: A case report

Journal of Addictive Diseases

Volumn 31, Issue 4, 2012, Pages 329-331

  Tenore, Peter L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Buprenorphine; enzymatic immunoassay; false positive buprenorphine; morphine; oxycodone

Indexed keywords

BUPRENORPHINE; MORPHINE SULFATE; OXYCODONE; PREGABALIN;

ADULT; ARTICLE; CASE REPORT; COMPRESSION FRACTURE; DRUG MEGADOSE; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; HUMAN; LOW BACK PAIN; MALE; MASS FRAGMENTOGRAPHY; OSTEOMYELITIS; SPINE FRACTURE; URINALYSIS; VERTEBRAL CANAL STENOSIS;

ANALGESICS, OPIOID; BUPRENORPHINE; CHRONIC DISEASE; ENZYME ASSAYS; FALSE POSITIVE REACTIONS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MORPHINE; OXYCODONE; REAGENT KITS, DIAGNOSTIC;

EID: 84871984000     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2012.735598     Document Type: Article

References (5)

1. Kosten, T R, and, Fiellin, D A. 2004. U.S. National Buprenorphine Implementation Program. Buprenorphine for office-based practice: consensus conference overview. Am J Addict, 13: S1-7.
2. Salima, S, Mindy, J, Bishop, K. 2008. Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine. J Anayl Tox, 32: 339-43.
3. Bottcher, M, and, Olof, B. 2005. Evaluation of buprenorphine CEDIA assay versus GCMS and ELISA using urine samples from patients in substitution treatment. J Analy Tox, 29: 166-74.
4. CEDIA Buprenorphine package insert data, 94538 Fremont, CA: Microgenics Corporation, 46360 Freemont Blvd.
5. Brunton, L, Lazo, J, and, Parker, K. 2011. Goodman and Gilman's the pharmacological basis of therapeutics. 12th ed, New York, NY: McGraw-Hill.